TriSalus Life Sciences, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
61.5M
on 2026-06-30, from 26.8M on 2024-03-31 10-Q ↗
a raise that quarter, at its price
5 of its filings are not read yet.
Cash
8.1 quarters
$46.3M on 2026-06-30 ÷ $5.7M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-02-19 | Public offering | 9,756,100 | $4.10 | $40.0M | 424B5 ↗ |
| 2025-04-30 | Private placement | 5,500,000 | $4.00 | $22.0M | 8-K ↗ |
Also on file: up to $50.0M notes agreed 2025-02-18 8-K ↗